Absolute lymphocyte count (ALC) ? /mm Absolute lymphocyte count (ALC) /L Adequate organ function within days of study registration including:\r\n* Absolute lymphocyte count (ALC) >= . x ^/L Absolute lymphocyte count (ALC) >= / mm^ Absolute lymphocyte count (ALC) >= cells/ul PART I: Absolute lymphocyte count (ALC) >= cells/mm^ PART II: ALC >= cells/mm^ Absolute lymphocyte count (ALC) of > , K/uL Absolute lymphocyte count (ALC) ? /mm^, and absolute number of CD+ T cells > /mm^ Absolute blood lymphocyte (ALC) >= cells/ul\r\n* If subject has an apheresis product or T cells available for manufacturing of T cell product, there is no minimum ALC requirement Absolute blood lymphocyte (ALC) >= cells/ul\r\n* If subject has an apheresis product or T cells available for manufacturing of T cell product, there is no minimum ALC requirement Absolute lymphocyte count (ALC) >= . x ^/L. Absolute lymphocyte count (ALC) > cells/mm Absolute lymphocyte count (ALC) >= /mm^ Patient must have no persistent toxicities from prior therapy >= grade with the exception of\r\nhematologic indices (i.e., hemoglobin, white blood cell count [WBC], ANC, absolute lymphocyte count [ALC]) Absolute lymphocyte count (ALC) >= /uL Absolute lymphocyte count (ALC) >= cells/ul Absolute lymphocyte count (ALC) > Patients must have absolute lymphocyte counts (ALC) of more than , cell/mm^ Absolute lymphocyte count (ALC) > /ul Absolute lymphocyte count (ALC) >= /mm^ Absolute T-cell count (ATC) at screening >= . K/microL. This is defined as CD+ T-cell percent (expressed as fraction of %) multiplied by the absolute lymphocyte count (ALC, expressed in K/microL). Absolute lymphocyte count (ALC) >= /uL Absolute lymphocyte count (ALC) ? /mm Progressive lymphocytosis in the absence of infection, with an increase in blood Absolute Lymphocyte Count (ALC) >=% over a -month period, or a lymphocyte doubling time (LDT) of < months (as long as initial ALC was >=/l). either ALC > /L, or Absolute lymphocyte count (ALC) ? e/L Patients with a diagnosis of CLL (any stage) with absolute lymphocyte count (ALC) >= x /l, requiring therapy Absolute lymphocyte count (ALC) >= /uL obtained =< days prior to registration For Phase b individuals: absolute lymphocyte count (ALC) > /?L in peripheral blood. Absolute lymphocyte count (ALC) >= . X ^/L Absolute lymphocyte count (ALC) >= /?L ALC >/uL Absolute lymphocyte count (ALC) ? ,/?l (? /?l after stem cell transplant) Note: After completion of dose escalation, patients with AML are not required to meet these hematologic criteria.